Cadrenal Therapeutics Inc. Common Stock (CVKD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cadrenal Therapeutics Inc...

    NASDAQ: CVKD · Real-Time Price · USD
    14.31
    0.12 (0.85%)
    At close: Oct 03, 2025, 3:59 PM
    14.36
    0.35%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Cadrenal Therapeutics Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    PE Ratio
    		 -1.66 -1.15 -7.14
    PEG Ratio
    		 0.18 -0.1 n/a
    PS Ratio
    		 n/a n/a n/a
    PB Ratio
    		 2.38 1.25 -8.64
    P/FCF Ratio
    		 -2.4 -2.73 -39.79
    P/OCF Ratio
    		 -2.4 -2.73 -39.79
    OCF/S Ratio
    		 n/a n/a n/a
    Debt / Equity Ratio
    		 n/a 0.00 -0.12
    Quick Ratio
    		 3.77 10.27 0.55
    Current Ratio
    		 3.77 10.27 0.55
    Asset Turnover
    		 n/a n/a n/a
    Interest Coverage
    		 n/a -446.34 -25.22
    Return on Equity
    		 -1.43 -1.09 1.21
    Return on Assets
    		 -1.05 -0.98 -8.63
    Return on Invested Capital
    		 -1.47 -0.99 5.51
    Dividend Yield
    		 n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a

    Add to Watchlist